FCRX trades at Wall Street's consensus target of —.
Last 12 months price action with 12-month analyst target path
The base valuation assumes FCRX achieves its forward estimates and maintains a stable P/E multiple of 15.1x. This scenario reflects the blended consensus of 5 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 28, 2026, Crescent Capital BDC, Inc. (FCRX) has a Wall Street consensus price target of N/A, based on estimates from 5 covering analysts. The company has a market capitalization of $932M.
Analyst price targets range from a low of N/A to a high of N/A.
The current analyst consensus rating is Buy, with 4 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, FCRX trades at a trailing P/E of 27.1x and forward P/E of 15.1x. Analysts expect EPS to grow +78.5% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $27.23, with bear and bull scenarios of $17.15 and $35.87 respectively. Model confidence stands at 45/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
ARCCAres Capital Corporation | $13.1B | $18.19 | $19.00 | +4.5% | Buy | 9.5x | 32 |
FSCOFS Credit Opportunities Corp. | $977M | $4.83 | — | — | — | — | — |
GBDCGolub Capital BDC, Inc. | $3.3B | $12.59 | $14.25 | +13.2% | Buy | 9.2x | 12 |
OBDCBlue Owl Capital Corporation | $5.4B | $10.82 | $13.00 | +20.1% | Buy | 8.4x | 13 |
TPVGTriplePoint Venture Growth BDC Corp. | $191M | $4.70 | $8.95 | +90.4% | Hold | 5.0x | 12 |
CGBDCarlyle Secured Lending, Inc. | $751M | $10.81 | $12.00 | +11.0% | Hold | 7.9x | 7 |
HTGCHercules Capital, Inc. | $2.9B | $15.58 | $16.50 | +5.9% | Buy | 8.1x | 31 |
SLRCSLR Investment Corp. | $678M | $12.42 | $14.50 | +16.7% | Buy | 9.1x | 15 |
PFLTPennantPark Floating Rate Capital Ltd. | $734M | $7.40 | $9.75 | +31.8% | Buy | 6.9x | 11 |
GSBDGoldman Sachs BDC, Inc. | $1.1B | $9.47 | $9.00 | -5.0% | Hold | 8.4x | 9 |
Quick answers to the most common questions about buying FCRX stock.
The consensus price target for FCRX is $N/A, close to the current price of $25.1699 (N/A% implied move). Based on 5 analyst estimates, the stock appears fairly valued near current levels.
FCRX has a consensus rating of "Buy" based on 5 Wall Street analysts. The rating breakdown is predominantly bullish, with 4 Buy/Strong Buy ratings. The consensus 12-month price target of $N/A implies N/A% upside from current levels.
With a forward P/E of 15.1125x, FCRX trades at a relatively low valuation. The consensus target of $N/A implies N/A% appreciation, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $N/A for FCRX, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. Our quantitative valuation model projects a bull case target of $36 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
FCRX is moderately covered, with 5 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 4 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month FCRX stock forecast based on 5 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $27, with bear/bull scenarios of $17/$36.
Our quantitative valuation model calculates FCRX's fair value at $27 (base case), with a bear case of $17 and bull case of $36. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 45/100.
FCRX trades at a forward P/E ratio of 15.1x based on next-twelve-months earnings estimates compared to a trailing P/E of 27.1x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
FCRX appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
FCRX analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground. Our model's $17-$36 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.